Citations

Showing 10 of 108119 citations.

The Anti-Inflammatory Effect of the β1-Adrenergic Receptor Antagonist Metoprolol on High Glucose Treated Human Microvascular Retinal Endothelial Cells
Giurdanella, Giovanni , Longo, Anna , Distefano, Alfio , Olivieri, Melania, Cristaldi, Martina, Cosentino, Alessia , Agafonova, Aleksandra , Caporarello, Nunzia , Lupo, Gabriella , Anfuso, Carmelina Daniela , Caporarello, Nunzia

Mayo Clinic

Cells | December 27, 2021 | Volume: 11 | Issue: 1 | Pages: 51

10.3390/cells11010051 | PMID 35011613 Get It

Hyperglycemia-induced impairment of the blood-retinal barrier represents the main pathological event in diabetic retinopathy that is elicited by a reduced cellular response to an accumulation of reactive oxygen species (ROS) and increased inflammation. The purpose of the study was to evaluate whether the selective β1-adrenoreceptor (β1-AR) antagonist metoprolol could modulate the inflammatory response to hyperglycemic conditions. For this purpose, human retinal endothelial cells (HREC) were treated with normal (5 mM) or high glucose (25 mM, HG) in the presence of metoprolol (10 μM), epinephrine (1 μM), or both compounds. Metoprolol prevented both the HG-induced reduction of cell viability (MTT assays) and the modulation of the angiogenic potential of HREC (tube formation assays) reducing the TNF-α, IL-1β, and VEGF mRNA levels (qRT-PCR). Moreover, metoprolol prevented the increase in phospho-ERK1/2, phospho-cPLA2, COX2, and protein levels (Western blot) as well as counteracting the translocation of ERK1/2 and cPLA2 (high-content screening). Metoprolol reduced ROS accumulation in HG-stimulated HREC by activating the anti-oxidative cellular response mediated by the Keap1/Nrf2/HO-1 pathway. In conclusion, metoprolol exerted a dual effect on HG-stimulated HREC, decreasing the activation of the pro-inflammatory ERK1/2/cPLA2/COX2 axis, and counteracting ROS accumulation by activating the Keap1/Nrf2/HO-1 pathway.
The Effect of Plating on Adjacent Segments in Anterior Cervical Discectomy and Fusions in Patients with Degenerative Spine Disease: A Retrospective Cohort Study
Vega, Carlos Perez, Richter, Kent R. , Richter, Reed, Vivas-Buitrago, Tito , Neal, Matthew T. , Quiñones‐Hinojosa, Alfredo , L Heemskerk, Johan, A Domingo, Ricardo, R Richter, Kent, G Vivas-Buitrago, Tito, T Neal, Matthew, Heemskerk, Johan L. , Domingo, Ricardo A. , Richter, Reed, Abode-Iyamah, Kingsley

Mayo Clinic

Spine Surgery and Related Research | December 26, 2021 | Volume: 6 | Issue: 4 | Pages: 350-357

10.22603/ssrr.2021-0073 | PMID 36051674 Get It

Revisiting the role of surgery in the treatment of Graves’ disease
Cohen, Oded , Ronen, Ohad , Khafif, Avi, Rodrigo, Juan P. , Simó, Ricard , Pace‐Asciak, Pia , Mikkelsen, Lauge Hjorth , Kowalski, Luiz Paulo , Olsen, Kerry D., Sanabria, Álvaro , Babighian, Silvia , Shaha, Ashok R. , Zafereo, Mark , Ferlito, Alfio , Sanabria, Alvaro , Rodrigo, Juan P , Kowalski, Luiz P , Randolph, Gregory William , Tufano, Ralph Patrick

Mayo Clinic

Clinical Endocrinology | December 26, 2021 | Volume: 96 | Issue: 6 | Pages: 747-757

10.1111/cen.14653 | PMID 34954838 Get It

AbstractGraves’ disease (GD) can be managed by antithyroid drugs (ATD), radioactive iodine (RAI) and surgery. Thyroidectomy offers the highest success rates for both primary and persistent disease, yet it is the least recommended or utilized option reaching <1% for primary disease and <25% for persistent disease. Several surveys have found surgery to be the least recommended by endocrinologists worldwide. With the development of remote access thyroidectomies and intraoperative nerve monitoring of the recurrent laryngeal nerve, combined with current knowledge of possible risks associated with RAI or failure of ATDs, revaluation of the benefit to harm ratio of surgery in the treatment of GD is warranted. The aim of this review is to discuss possible reasons for the low proportion of surgery in the treatment of GD, emphasizing an evidence‐based approach to the clinicians’ preferences for surgical referrals, surgical indications and confronting traditional reasons and concerns relating to the low referral rate with up‐to‐date data.
Tiger-Striped PASH: Recognition of a Unique Morphology Allows for a Zippered-Up Diagnosis of Pseudoangiomatous Stromal Hyperplasia of Breast
Sakibuzzaman, Mohamad, Kendziora, Ryan W., Ghosh, Toshi, Solanki, Malvika , Conners, Amy Lynn , Ahlberg, Lisa J., Sturgis, Charles D. , Solanki, Malvika H

Mayo Clinic

Case Reports in Pathology | December 26, 2021 | Volume: 2021 | Issue: No issue available | Pages: 1-5

10.1155/2021/7697987 | PMID 34987877 Get It

Pseudoangiomatous stromal hyperplasia (PASH) of the breast is histologically characterized by anastomosing and slit-like spaces invested by collagenous stroma and lined by flattened, spindle cells. These clear spaces that may mimic microscopic vascular channels do not contain red blood cells. Immunohistochemistry (IHC) studies may also help to confirm a diagnosis of PASH, with the spindled cells marking positively with CD34 and PR while demonstrating no reactivity with more specific endothelial antigens such as CD31 and ERG. In the current case, a 39-year-old female was diagnosed with cellular PASH of the right breast with unique histological patterns showing “tiger-striped” and “zippered” histologies. To our knowledge, this is the first report of these unique variant PASH morphologies.
Plasma-Soluble Biomarkers for Fibrodysplasia Ossificans Progressiva (FOP) Reflect Acute and Chronic Inflammatory States
Pignolo, Robert J. , McCarrick-Walmsley, Ruth, Qiu, Shirley , Hunter, Jeffrey W. , Barr, Sharon, Zhang, Hui , Wang, Haitao , Qiu, Shirley, He, Kevin , Kaplan, Frederick S.

Mayo Clinic

Journal of Bone and Mineral Research | December 26, 2021 | Volume: 37 | Issue: 3 | Pages: 475-483

10.1002/jbmr.4492 | PMID 34954853 Get It

ABSTRACT Fibrodysplasia ossificans progressiva (FOP) is a progressive, debilitating genetic disease in which skeletal muscle and connective tissue is episodically replaced by heterotopic bone. Discovery of surrogate biomarkers of disease (genotype)-related and flare-up-associated activity of FOP in a readily accessible matrix, such as plasma, would facilitate an understanding of the complex pathophysiology of FOP, aid patient care, and provide a valuable tool for the development and monitoring of potential therapeutics. In a case–control study, using a carefully collected and curated set of plasma samples from 40 FOP patients with the classic ACVR1R206H mutation and 40 age- and sex-matched controls, we report the identification of disease-related and flare-up-associated biomarkers of FOP using a multiplex analysis of 113 plasma-soluble analytes. Adiponectin (implicated in hypoxia, inflammation, and heterotopic ossification) as well as tenascin-C (an endogenous activator of innate immune signaling through the TLR4 pathway and a substrate for kallikrein-7) were highly correlated with FOP genotype, while kallikrein-7 was highly correlated with acute flare-up status. Plasma-soluble biomarkers for FOP support a flare-up-related acute inflammatory phase of disease activity superimposed on a genotypic background of chronic inflammation. © 2021 American Society for Bone and Mineral Research (ASBMR).
Nonsurgical Management of Thyroid Nodules: The Role of Ablative Therapies
Stan, Marius N. , Schmitz, John J. , Castro, M. Regina , Stan, Marius N , Papaleontiou, Maria

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | December 25, 2021 | Volume: 107 | Issue: 5 | Pages: 1417-1430

10.1210/clinem/dgab917 | PMID 34953163 Get It

Abstract Context After a thorough evaluation most thyroid nodules are deemed of no clinical consequence and can be observed. However, when they are compressive, toxic, or involved by papillary thyroid carcinoma surgery or radioactive iodine (RAI) (if toxic) are the treatments of choice. Both interventions can lead to hypothyroidism and other adverse outcomes (eg, scar, dysphonia, logistical limitation with RAI). Active surveillance might be used for papillary thyroid microcarcinoma (PTMC) initially, but anxiety leads many cases to surgery later. Several ablative therapies have thus evolved over the last few years aimed at treating these nodules while avoiding described risks. Cases We present 4 cases of thyroid lesions causing concern (compressive symptoms, thyrotoxicosis, anxiety with active surveillance of PTMC). The common denominator is patients’ attempt to preserve thyroid function, bringing into focus percutaneous ethanol injection (PEI) and thermal ablation techniques (radiofrequency ablation [RFA] being the most common). We discuss the evidence supporting these approaches and compare them with standard therapy, where evidence exists. We discuss additional considerations for the utilization of these therapies, their side-effects, and conclude with a simplified description of how these procedures are performed. Conclusion Thermal ablation, particularly RFA, is becoming an attractive option for managing a subgroup of solid thyroid nodules, while PEI has a role in managing thyroid cysts and a select group of PTMC. Their role in the algorithm of thyroid nodule management is still being refined and technical expertise will be essential to reproduce the reported results into everyday practice.
Objective sleep profile in LGI1/CASPR2 autoimmunity
Devine, Michelle F., Feemster, John, Lieske, E.A., Sandness, David J., Steele, Tyler, Timm, Paul, Mandrekar, Jay , Boeve, Bradley F. , Silber, Michael H. , Dubey, Divyanshu , Louis, Erik K. St. , Devine, Michelle , Feemster, John C, Lieske, Elizabeth A, Timm, Paul C, Boeve, Brad , St Louis, E K , Dubey, Divyanshu , McCarter, Stuart J. , McKeon, Andrew

Mayo Clinic

Sleep | December 25, 2021 | Volume: 45 | Issue: 2 | Pages: No page available

10.1093/sleep/zsab297 | PMID 34953167 Get It

AbstractStudy ObjectivesRapid eye movement (REM) sleep behavior disorder (RBD) and other sleep disturbances are frequent in leucine-rich, glioma inactivated protein 1-IgG (LGI1) and contactin-associated protein 2-IgG (CASPR2) autoimmunity, yet polysomnographic analyses of these disorders remain limited. We aimed to characterize clinical presentations and analyze polysomnographic manifestations, especially quantitative REM sleep without atonia (RSWA) in LGI1/CASPR2-IgG seropositive (LGI/CASPR2+) patients.MethodsWe retrospectively analyzed clinical and polysomnographic features and quantitative RSWA between LGI1+/CASPR2+ patients and age-sex matched controls. Groups were compared with Wilcoxon rank-sum and chi-square tests. Combined submentalis and anterior tibialis (SM + AT) RSWA was the primary outcome.ResultsAmong 11 (LGI1+, n = 9; CASPR2+, n = 2) patients, Morvan syndrome sleep features were present in seven (63.6%) LGI1+/CASPR2+ patients, with simultaneous insomnia and dream enactment behavior (DEB) in three (27.3%), and the most common presenting sleep disturbances were DEB (n = 5), insomnia (n = 5), and sleep apnea (n = 8; median apnea-hypopnea index = 15/hour). Median Epworth Sleepiness Scale was nine (range 3–24; n = 10), with hypersomnia in four (36.4%). LGI1+/CASPR2+ patients had increased N1 sleep (p = .02), decreased REM sleep (p = .001), and higher levels of SM + AT any RSWA (p &lt; .001). Eight of nine (89%) LGI1+ exceeded RBD RSWA thresholds (DEB, n = 5; isolated RSWA, n = 3). RSWA was greater in AT than SM. All 10 LGI1+/CASPR2+ patients treated with immunotherapy benefitted, and 5/10 had improved sleep disturbances.ConclusionsLGI1/CASPR2-IgG autoimmunity is associated with prominent dream enactment, insomnia, RSWA, sleep apnea, and shallower sleep. Polysomnography provides objective disease markers in LGI1+/CASPR2+ autoimmunity and immunotherapy may benefit associated sleep disturbances.
Bone Microarchitecture Phenotypes Identified in Older Adults Are Associated With Different Levels of Osteoporotic Fracture Risk
Whittier, Danielle E. , Hannan, Marian T. , Burt, Lauren A. , Hanley, David A. , Biver, Emmanuel , Szulc, Paweł , Sornay‐Rendu, Elisabeth , Merle, Blandine , Lespessailles, Éric , Wong, Andy Kin On , Ferrari, Serge , Bouxsein, Mary , Samelson, Elizabeth J , Hannan, Marian T , Burt, Lauren A , Biver, Emmanuel , Szulc, Pawel , Sornay-Rendu, Elisabeth , Chapurlat, Roland D , Goltzman, David , Khosla, Sundeep , Ferrari, Serge , Bouxsein, Mary L , Kiel, Douglas P , Boyd, Steven K , Lespessailles, Eric , Whittier, Danielle E , Wong, Andy Kin On , Khosla, Sundeep , Kiel, Douglas P. , Boyd, Steven K.

Mayo Clinic

Journal of Bone and Mineral Research | December 25, 2021 | Volume: 37 | Issue: 3 | Pages: 428-439

10.1002/jbmr.4494 | PMID 34953074 Get It

ABSTRACT Prevalence of osteoporosis is more than 50% in older adults, yet current clinical methods for diagnosis that rely on areal bone mineral density (aBMD) fail to detect most individuals who have a fragility fracture. Bone fragility can manifest in different forms, and a “one-size-fits-all” approach to diagnosis and management of osteoporosis may not be suitable. High-resolution peripheral quantitative computed tomography (HR-pQCT) provides additive information by capturing information about volumetric density and microarchitecture, but interpretation is challenging because of the complex interactions between the numerous properties measured. In this study, we propose that there are common combinations of bone properties, referred to as phenotypes, that are predisposed to different levels of fracture risk. Using HR-pQCT data from a multinational cohort (n = 5873, 71% female) between 40 and 96 years of age, we employed fuzzy c-means clustering, an unsupervised machine-learning method, to identify phenotypes of bone microarchitecture. Three clusters were identified, and using partial correlation analysis of HR-pQCT parameters, we characterized the clusters as low density, low volume, and healthy bone phenotypes. Most males were associated with the healthy bone phenotype, whereas females were more often associated with the low volume or low density bone phenotypes. Each phenotype had a significantly different cumulative hazard of major osteoporotic fracture (MOF) and of any incident osteoporotic fracture (p &lt; 0.05). After adjustment for covariates (cohort, sex, and age), the low density followed by the low volume phenotype had the highest association with MOF (hazard ratio = 2.96 and 2.35, respectively), and significant associations were maintained when additionally adjusted for femoral neck aBMD (hazard ratio = 1.69 and 1.90, respectively). Further, within each phenotype, different imaging biomarkers of fracture were identified. These findings suggest that osteoporotic fracture risk is associated with bone phenotypes that capture key features of bone deterioration that are not distinguishable by aBMD. © 2021 American Society for Bone and Mineral Research (ASBMR).
Gradual prolongation of PR interval followed by a pause. What is the mechanism?
Ghosh, Anindya , Raja, Deep Chandh , Deshmukh, Abhishek , Pandurangi, Ulhas M. , Raja, Deep C

Mayo Clinic

Journal of Cardiovascular Electrophysiology | December 25, 2021 | Volume: 33 | Issue: 3 | Pages: 540-543

10.1111/jce.15338 | PMID 34953092 Get It

Survival of the less‐fit
Carey, Elizabeth J.

Mayo Clinic

Hepatology | December 25, 2021 | Volume: 75 | Issue: 6 | Pages: 1368-1369

10.1002/hep.32300 | PMID 34953148 Get It